Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,651 | -4,385 | -2,339 | -1,003 | -1,859 |
| Depreciation Amortization | 8 | 8 | 85 | 83 | 76 |
| Accounts receivable | -134 | N/A | 165 | -241 | -417 |
| Other Working Capital | -206 | -382 | -26 | -530 | -1,360 |
| Other Operating Activity | 9,565 | 3,660 | -2,624 | -2,187 | -61 |
| Operating Cash Flow | $-1,418 | $-1,099 | $-4,739 | $-3,878 | $-3,621 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | 750 | N/A | 750 |
| Other Investing Activity | 0 | 0 | 750 | 750 | 750 |
| Investing Cash Flow | $N/A | $N/A | $750 | $750 | $750 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,000 | N/A | 6 | 6 | 5 |
| Other Financing Activity | 1,337 | 1,794 | 0 | 0 | 0 |
| Financing Cash Flow | $5,337 | $1,794 | $6 | $6 | $5 |
| Beginning Cash Position | 259 | 259 | 4,242 | 4,242 | 4,242 |
| End Cash Position | 4,178 | 954 | 259 | 1,120 | 1,376 |
| Net Cash Flow | $3,919 | $695 | $-3,983 | $-3,122 | $-2,866 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,418 | -1,099 | -4,739 | -3,878 | -3,621 |
| Free Cash Flow | -1,418 | -1,099 | -4,739 | -3,878 | -3,621 |